Walgreens’ Quarterly Earnings Plummet Amid Increased Competition, Shrinking Prescription Drug Profits

Apart from prescription drug struggles, for the first time, Walgreens executives also seemed to acknowledge fallout from the acquisition of health insurer Aetna by rival CVS Health Corp. Other pharmaceutical news focuses on congressional drug pricing efforts, the ghosts of J.P. Morgan's past, and a look ahead to 2020.

from Kaiser Health News https://ift.tt/2R1lA7N